Thus, treatment aimed at maintaining lower levels of IL-8 and GrzB and higher levels of IP-10 may suppress the progression of SOC in chronic-phase SJS/TEN cases. This evidence concerns the gene CXCL8 and Schwartz-Jampel syndrome.